Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration
A goal of regenerative medicine is to use induced pluripotent stem cells to generate an autologous graft for transplantation. This study tests the feasibility of the approach to treat age-related macular degeneration. Age-related macular degeneration (AMD) is one of the most prevalent retinal diseas...
Saved in:
Published in | The New England journal of medicine Vol. 376; no. 11; pp. 1038 - 1046 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Massachusetts Medical Society
16.03.2017
|
Series | Brief Report |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A goal of regenerative medicine is to use induced pluripotent stem cells to generate an autologous graft for transplantation. This study tests the feasibility of the approach to treat age-related macular degeneration.
Age-related macular degeneration (AMD) is one of the most prevalent retinal diseases that threaten vision in older populations in developed countries.
1
–
4
Neovascular (also called “wet”) AMD is more prevalent than atrophic (or “dry”) AMD in Japan
5
and is associated with the ectopic development of a choroidal neovascular membrane in the subretinal space of the center of the retina (the macula). Physical disruption and functional impairment of the retinal pigment epithelium (RPE), a monolayer sheet of cells that supports the overlying photoreceptors and underlying choroidal vasculature, occur in the course of wet AMD.
6
Current treatments of AMD that involve the . . . |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Case Study-2 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
ISSN: | 0028-4793 1533-4406 1533-4406 |
DOI: | 10.1056/NEJMoa1608368 |